| 1 |
Desantis V, Potenza MA, Sgarra L, Nacci C, Scaringella A, Cicco S, Solimando AG, Vacca A, Montagnani M. microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation. IJMS 2023;24:5307. [DOI: 10.3390/ijms24065307] [Reference Citation Analysis]
|
| 2 |
Soffritti I, D'Accolti M, Maccari C, Bini F, Mazziga E, Arcangeletti MC, Caselli E. Coinfection of Dermal Fibroblasts by Human Cytomegalovirus and Human Herpesvirus 6 Can Boost the Expression of Fibrosis-Associated MicroRNAs. Microorganisms 2023;11. [PMID: 36838377 DOI: 10.3390/microorganisms11020412] [Reference Citation Analysis]
|
| 3 |
Zheng WB, Cai L, Zou Y, Gao WW, Liu Q, Zhu XQ. Altered miRNA Expression Profiles in the Serum of Beagle Dogs Experimentally Infected with Toxocara canis. Animals (Basel) 2023;13. [PMID: 36670839 DOI: 10.3390/ani13020299] [Reference Citation Analysis]
|
| 4 |
Naranjo M, Breedon SA, Storey KB. Cardiac microRNA expression profile in response to estivation. Biochimie 2023:S0300-9084(23)00001-9. [PMID: 36627041 DOI: 10.1016/j.biochi.2023.01.001] [Reference Citation Analysis]
|
| 5 |
Abdel-Nasser ZM, Zaafan MA, Abdelhamid AM. Modulation of the miR-122/Sirt-6/ACE2 axis on experimentally-induced myocardial infarction. Chem Biol Interact 2023;369:110276. [PMID: 36414029 DOI: 10.1016/j.cbi.2022.110276] [Reference Citation Analysis]
|
| 6 |
Alieva AM, Teplova NV, Reznik EV, Baykova IE, Shnakhova LM, Totolyan GG, Valiev RK, Skripnichenko EA, Kotikova IA, Nikitin IG. miRNA-122 as a new player in cardiovascular disease. Medical Journal of the Russian Federation 2023;28:451-463. [DOI: 10.17816/medjrf111180] [Reference Citation Analysis]
|
| 7 |
Luo HY, Li G, Liu YG, Wei YH, Chen JB, Gu XF, Tang JQ, Zhao Y, Su CH, Xiao LY, Xiong F, Zheng ZD, Wang SY, Zha LY. The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes. Curr Issues Mol Biol 2022;44:4822-37. [PMID: 36286043 DOI: 10.3390/cimb44100328] [Reference Citation Analysis]
|
| 8 |
Liu L, Zhang Y, Chen Y, Zhao Y, Shen J, Wu X, Li M, Chen M, Li X, Sun Y, Gu L, Li W, Wang F, Yao L, Zhang Z, Xiao Z, Du F. Therapeutic prospects of ceRNAs in COVID-19. Front Cell Infect Microbiol 2022;12:998748. [DOI: 10.3389/fcimb.2022.998748] [Reference Citation Analysis]
|
| 9 |
Raziyeva K, Kim Y, Zharkinbekov Z, Temirkhanova K, Saparov A. Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction. Biomedicines 2022;10:2178. [DOI: 10.3390/biomedicines10092178] [Reference Citation Analysis]
|
| 10 |
Gao X, Yang Q, Zhang S, Huang X, Yan Z, Wang P, Gun S. LncRNA ALDB-898 modulates intestinal epithelial cell damage caused by Clostridium perfringens type C in piglet by regulating ssc-miR-122-5p/OCLN signaling. Mol Immunol 2022;149:143-56. [PMID: 35834877 DOI: 10.1016/j.molimm.2022.07.002] [Reference Citation Analysis]
|
| 11 |
Li D, Qu J, Yuan X, Zhuang S, Wu H, Chen R, Wu J, Zhang M, Ying L, Murray P. Mesenchymal Stem Cells Alleviate Renal Fibrosis and Inhibit Autophagy via Exosome Transfer of miRNA-122a. Stem Cells International 2022;2022:1-14. [DOI: 10.1155/2022/1981798] [Reference Citation Analysis]
|
| 12 |
Wang F, He Y, Yao N, Ruan L, Tian Z, Abdel-rahman AA. Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction. Cardiovascular Therapeutics 2022;2022:1-13. [DOI: 10.1155/2022/1308651] [Reference Citation Analysis]
|
| 13 |
Liang X, Hu M, Yuan W, Liu Y, Li J, Bai C, Yuan Z. MicroRNA-4487 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting RAS p21 protein activator 1. Pathology - Research and Practice 2022;234:153903. [DOI: 10.1016/j.prp.2022.153903] [Reference Citation Analysis]
|
| 14 |
Liu Y, Hu J, Wang W, Wang Q. MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3. Cardiovasc Drugs Ther 2022. [PMID: 35416554 DOI: 10.1007/s10557-021-07312-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Song J, Zhang Z, Dong Z, Liu X, Liu Y, Li X, Xu Y, Guo Y, Wang N, Zhang M, Chen Y, Jin H, Zhong J. MicroRNA-122-5p Aggravates Angiotensin II-Mediated Myocardial Fibrosis and Dysfunction in Hypertensive Rats by Regulating the Elabela/Apelin-APJ and ACE2-GDF15-Porimin Signaling. J Cardiovasc Transl Res 2022. [PMID: 35174434 DOI: 10.1007/s12265-022-10214-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
郑 欣. Research Progress of Long Non-Coding RNA TINCR Involved in Tumor. ACM 2022;12:4632-4637. [DOI: 10.12677/acm.2022.125669] [Reference Citation Analysis]
|
| 17 |
Yang X, Feng J, Liang W, Zhu Z, Chen Z, Hu J, Yang D, Ding G. Roles of SIRT6 in kidney disease: a novel therapeutic target. Cell Mol Life Sci 2021. [PMID: 34950960 DOI: 10.1007/s00018-021-04061-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Ali F, Shen A, Islam W, Saleem MZ, Muthu R, Xie Q, Wu M, Cheng Y, Chu J, Lin W, Peng J. Role of MicroRNAs and their corresponding ACE2/Apelin signaling pathways in hypertension. Microb Pathog 2021;162:105361. [PMID: 34919993 DOI: 10.1016/j.micpath.2021.105361] [Reference Citation Analysis]
|
| 19 |
Zhou H, Tang W, Yang J, Peng J, Guo J, Fan C. MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure. Front Cardiovasc Med 2021;8:773083. [PMID: 34869689 DOI: 10.3389/fcvm.2021.773083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 20 |
Nikdoust F, Pazoki M, Mohammadtaghizadeh M, Aghaali MK, Amrovani M. Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease. Cardiovasc Toxicol 2021. [PMID: 34669097 DOI: 10.1007/s12012-021-09700-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 21 |
Wang L, Chen H. Correlation between serum miR-122 and myocardial damage and ventricular function in patients with essential hypertension. J Thorac Dis 2021;13:4999-5006. [PMID: 34527338 DOI: 10.21037/jtd-21-677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 22 |
Madonna R, Moscato S, Polizzi E, Pieragostino D, Cufaro MC, Del Boccio P, Bianchi F, De Caterina R, Mattii L. Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model. Int J Mol Sci 2021;22:5815. [PMID: 34071707 DOI: 10.3390/ijms22115815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Song W, Zhang T, Yang N, Zhang T, Wen R, Liu C. Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1. Bioengineered 2021;12:1902-15. [PMID: 34002676 DOI: 10.1080/21655979.2021.1926201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 24 |
Fernández-Tussy P, Ruz-Maldonado I, Fernández-Hernando C. MicroRNAs and Circular RNAs in Lipoprotein Metabolism. Curr Atheroscler Rep 2021;23:33. [PMID: 33970351 DOI: 10.1007/s11883-021-00934-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 25 |
Shi Y, Zhang Z, Yin Q, Fu C, Barszczyk A, Zhang X, Wang J, Yang D. Cardiac-specific overexpression of miR-122 induces mitochondria-dependent cardiomyocyte apoptosis and promotes heart failure by inhibiting Hand2. J Cell Mol Med 2021;25:5326-34. [PMID: 33942477 DOI: 10.1111/jcmm.16544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Tian C, Gao L, Zucker IH. Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs. Free Radic Biol Med 2021;167:218-31. [PMID: 33741451 DOI: 10.1016/j.freeradbiomed.2021.03.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
